Mycophenolate mofetil (MMF)/tacrolimus (FK506) is an effective and safe regimen for graft versus host disease (GVHD) prophylaxis in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Altered MMF pharmacokinetics (PK) and association with acute GVHD

被引：0
|
作者：
Osunkwo, I [1 ]
Bessmertny, O [1 ]
Harrison, L [1 ]
Garvin, J [1 ]
George, D [1 ]
Bradley, MB [1 ]
DelToro, G [1 ]
Wischhover, C [1 ]
Wolownik, K [1 ]
van de Ven, C [1 ]
Cheung, YK [1 ]
Cairo, MS [1 ]
机构：
[1] Columbia Univ, New York, NY 10027 USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2988
引用
收藏
页码：528A / 528A
页数：1
相关论文
共 50 条
  • [21] Mycophenolate mofetil (MMF) as salvage treatment for graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT): Safety analysis
    Nash, RA
    Furlong, T
    Storb, R
    Anasetti, C
    Appelbaum, FR
    Deeg, HJ
    Doney, K
    Martin, P
    Witherspoon, R
    Sullivan, KM
    BLOOD, 1997, 90 (10) : 459 - 459
  • [22] Significant alterations of mycophenolate mofetil (MMF) pharmacokinetics in pediatric allogeneic stem cell transplant (AlloSCT) recipients: Alternate dosing is required in AlloSCT compared to solid organ autograft recipients.
    Bessmertny, O
    Harrison, L
    Osunkwo, I
    Wischhover, C
    Garvin, J
    George, D
    Del Toro, G
    Bradley, MB
    Cairo, MS
    BLOOD, 2002, 100 (11) : 418A - 419A
  • [23] Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients
    Kiehl, MG
    Schäfer-Eckart, K
    Kröger, M
    Bornhäuser, M
    Basara, N
    Blau, IW
    Kienast, J
    Fauser, AA
    Ehninger, G
    Armstrong, VW
    Shipkova, M
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2922 - 2924
  • [24] Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.
    Kiehl, MG
    Linck, D
    Schaefer-Eckart, K
    Kroeger, M
    Bronhaeuser, M
    Blau, IW
    Wandt, H
    Jenke, A
    Kienast, J
    Armstrong, VW
    Basara, N
    Schroeder, H
    Kraut, L
    Fauser, AA
    BLOOD, 2003, 102 (11) : 716A - 716A
  • [25] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [26] Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis
    Labrador, Jorge
    Lopez-Godino, Oriana
    Lopez-Corral, Lucia
    Perez-Lopez, Estefania
    Cabrero-Calvo, Monica
    Perez-Lopez, Roberto
    Mara Bastida, Jose
    Lopez-Parra, Miriam
    Alberca, Ignacio
    Ramon Gonzalez-Porras, Jose
    Caballero, Dolores
    BLOOD, 2012, 120 (21)
  • [27] A phase I/II study of mycophenolate mofetil (MMF) in combination with cyclosporine (CSP) for prophylaxis of graft versus host disease (GVHD) after myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT): Dose escalation of MMF.
    Nash, RA
    Johnston, L
    Parker, PM
    Slattery, JT
    Storer, B
    Furlong, T
    Anasetti, C
    Appelbaum, FR
    Lloid, CM
    Blume, K
    Deeg, HJ
    Forman, SJ
    Kiem, HP
    Martin, PJ
    Schubert, M
    Witherspoon, RP
    Storb, R
    BLOOD, 2003, 102 (11) : 240A - 240A
  • [28] Mycophenolate Mofitil (MMF) As Salvage Graft-Versus-Host Diseases (GVHD) Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation (HCT) After Early Discontinuation Of Tacrolimus and/Or Sirolimus Due To Toxicities
    Ali, Haris
    Palmer, Joycelynne
    Eroglu, Zeynep
    Stiller, Tracey
    Thomas, Sandra H.
    Khaled, Samer
    Shayani, Sepideh
    Parker, Pablo
    Forman, Stephen J.
    Nakamura, Ryotaro
    BLOOD, 2013, 122 (21)
  • [29] TACROLIMUS AND Q8H MYCOPHENOLATE MOFETIL (MMF) PROPHYLAXIS IN CHILDREN AND YOUNG ADULT (CAYA) RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) RESULTS IN AVERY LOW INCIDENCE OF GRADE II-IV ACUTE GVHD (AGVHD)
    Militano, Olga
    Ozkaynak, Mehmet Fevzi
    Adams, Debra
    Nickerson, Berkley
    van de Ven, Carmella
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 114 - 114
  • [30] Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome
    Sabry, Waleed
    Labbe, Annie-Claude
    Le Blanc, Richard
    Sauvageau, Guy
    Roy, Denis-Claude
    Busque, Lambert
    Cohen, Sandra
    Kiss, Thomas
    Lachance, Silvy
    Roy, Jean
    BLOOD, 2008, 112 (11) : 430 - 430
12345